Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
about
Human alpha-1-glycoprotein and its interactions with drugs.Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.Metabolic characterization of a tripeptide human immunodeficiency virus type 1 protease inhibitor, KNI-272, in rat liver microsomes.Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
P2860
Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Binding characteristics of KNI ...... eptide HIV protease inhibitor.
@en
Binding characteristics of KNI ...... eptide HIV protease inhibitor.
@nl
type
label
Binding characteristics of KNI ...... eptide HIV protease inhibitor.
@en
Binding characteristics of KNI ...... eptide HIV protease inhibitor.
@nl
prefLabel
Binding characteristics of KNI ...... eptide HIV protease inhibitor.
@en
Binding characteristics of KNI ...... eptide HIV protease inhibitor.
@nl
P2093
P1476
Binding characteristics of KNI ...... eptide HIV protease inhibitor.
@en
P2093
Kiriyama A
Nishiura T
Yamamoto Y
P304
P356
10.1002/(SICI)1099-081X(199612)17:9<739::AID-BDD987>3.0.CO;2-0
P577
1996-12-01T00:00:00Z